Brief: Adhera Therapeutics Inc Determined That Co Would Terminate Its Current Business Operations
17/12/2019 21:52
Dec 17 (Reuters) - Adhera Therapeutics Inc ATRX.PK :
* ADHERA THERAPEUTICS INC - DETERMINED THAT CO WOULD
TERMINATE ITS
CURRENT BUSINESS OPERATIONS
* ADHERA THERAPEUTICS - TERMINATION INCLUDES COMMERCIAL
OPERATIONS
RELATING TO SALE OF FDA APPROVED PRODUCT PRESTALIA(REG)
Source : (https://bit.ly/2Ev406u)
Further company coverage: ATRX.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adhera Therapeutics
See all newsBrief: Adhera Therapeutics Says Melior Pharmaceuticals II Terminates License Deal With Respect To MLR-1019
Brief: Adhera Therapeutics Announces CEO, Senior Management Changes, Plans For Nasdaq Uplist
Brief: Adhera Therapeutics Signs Letter Of Intent With Melior Pharmaceuticals Ii To Acquire A New Class Of Drug For Parkinson’S Disease
Ontario to begin offering second doses of COVID-19 vaccines
Brief: Adhera Therapeutics Inc Determined That Co Would Terminate Its Current Business Operations